SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
SonoThera has raised $125.0M in total funding. The most recent round was Series B. The last funding was announced in June 2026.
SonoThera's investors include RA Capital Management, ARCH Venture Partners, Vivo Capital, ARK Investment Management, Illumina Ventures.
SonoThera is headquartered in South San Francisco, United States.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
SonoThera is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SonoThera — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/sonothera. Accessed September 29, 2026.
VCBacked. (2026). SonoThera — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/sonothera
{{cite web |title=SonoThera — Funding & Investors |url=https://www.vcbacked.co/company/sonothera |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated